Validation of a Smartwatch in Persons With Multiple Sclerosis
Validation of a Commercially Available Smartwatch for Step Detection in Persons With Multiple Sclerosis
What it found
We found no results in the registry or in papers.
This trial finished 7 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- Comfortable walking velocity (CWV)
- Slow walking velocity (SWV: CWV - 20%)
- Fast walking velocity (FWV: CWV + 20%)
What it measured
Main measures
Step detection during comfortable walking
Following the comfortable walking velocity protocol, an average of 2 minutes
Walking and mobility
Other measures (2)
Step detection during slow walking
Following the slow walking velocity protocol, an average of 2 minutes
Walking and mobilityStep detection during fast walking
Following the fast walking velocity protocol, an average of 2 minutes
Walking and mobility
Who could take part
MS (type not specified) · 18 and over
Show the full criteria
Inclusion criteria
* Multiple Sclerosis with Expanded Disability Status Scale between 0 - 6.5 * Ability to walk 250 steps with or without an assistive device
Exclusion criteria
* Clinically relevant cardiovascular or orthopaedic disease * Severe polyneuropathy * Cognitive impairment
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
The study is designed to validate the accuracy of steps detected by a commercially available smartwatch in persons with multiple sclerosis. Specifically, the investigators examine whether a smartwatch can detect steps accurately during slow, comfortable and fast overground walking. The total steps counted by the smartwatch will be compared to those counted by an accelerometer commonly used in clinical studies and the actually walked steps.
Loading reviews and guidelines…
History
Started
May 2018
Main results due
Dec 2018
Finished
Jan 2019